Human Factors and Medicine (HFM-273) Long-Term Scientific Study on Chemical, Biological and Radiological Defence (LTSS) 2nd meeting was hosted by Science & Technology Organization in Paris, France 15-18 November 2016. JCBRN Defence CoE representative from Transformation Support Department has supported the meeting.

1.jpgHuman Factors and Medicine (HFM-273) Long-Term Scientific Study on Chemical, Biological and Radiological Defence held its second meeting at the CSO in Paris last week (15-18.11.2016). The study is chaired by Norway with participants from Belgium, Czech Republic, Finland, France, Germany, Netherlands, Romania, Sweden, Turkey, United Kingdom and United States. The study has links to other NATO bodies such as ACT, NCIA, NMSG, COMEDS/CBRNMed WG, JCBRN Defence COE, as well as to “Medical Chemical Defence against Chemical Warfare Agent Threats” (HFM-253) and other Science & Technology Organization (STO) activities, e.g. “State-of-the-Art in Research on Medical Countermeasures Against Biological Agents” (HFM-186).

Development of HFM-273 is in response to a changing geopolitical landscape where chemical, biological and radiological weapons have become one of the most penitent instruments of power. Consequently, there is an emerging requirement to assess new/future science and technology (S&T) areas that can support CBR Defence. This requirement is based on projected threats out to 2030, assesses critical information gaps and recommends the following Lines of Effort as aspects of a CBR Defence systems approach, CBR Threat Environments, New and Emerging Technologies, Sampling, Detection, Identification and Monitoring, Information Management, Physical Protection, Hazard Management, Medical Countermeasures and Casualty Care.

Author LTC Jarosław ŻOCHOWSKI
Transformation Support Department/Concept & Doctrines Section